Robert B. Wallis

920 total citations
46 papers, 794 citations indexed

About

Robert B. Wallis is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Robert B. Wallis has authored 46 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 17 papers in Cardiology and Cardiovascular Medicine and 14 papers in Hematology. Recurrent topics in Robert B. Wallis's work include Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Robert B. Wallis is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Robert B. Wallis collaborates with scholars based in United Kingdom, Switzerland and Slovakia. Robert B. Wallis's co-authors include M.C. Scrutton, J. John Holbrook, Michael C. Scrutton, Roger Kerry, John Ambler, Walter Märki, Roy T. Sawyer, Trevor J. Hallam, N. Thompson and Morris Tweed and has published in prestigious journals such as Biochemical Journal, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

Robert B. Wallis

45 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Wallis United Kingdom 18 240 233 200 148 113 46 794
Edward M. Driscoll United States 19 117 0.5× 512 2.2× 201 1.0× 152 1.0× 85 0.8× 41 1.1k
Shin-ichiro Ashida Japan 14 124 0.5× 202 0.9× 121 0.6× 114 0.8× 40 0.4× 27 606
Jane May United Kingdom 18 312 1.3× 497 2.1× 156 0.8× 131 0.9× 196 1.7× 38 1.0k
Carol M. Ingerman United States 12 128 0.5× 443 1.9× 160 0.8× 617 4.2× 48 0.4× 18 1.1k
H Weisenberger Germany 13 78 0.3× 214 0.9× 82 0.4× 77 0.5× 50 0.4× 21 463
Johan Beetens Belgium 17 82 0.3× 163 0.7× 221 1.1× 182 1.2× 20 0.2× 39 829
Yoshimi Imura Japan 16 79 0.3× 246 1.1× 338 1.7× 117 0.8× 17 0.2× 31 1.0k
H Hess United States 20 53 0.2× 269 1.2× 304 1.5× 62 0.4× 232 2.1× 62 1.3k
Martina H. Lundberg United Kingdom 10 70 0.3× 159 0.7× 79 0.4× 157 1.1× 45 0.4× 13 495
Miriam H. Fukami Norway 18 155 0.6× 69 0.3× 399 2.0× 58 0.4× 15 0.1× 31 919

Countries citing papers authored by Robert B. Wallis

Since Specialization
Citations

This map shows the geographic impact of Robert B. Wallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Wallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Wallis more than expected).

Fields of papers citing papers by Robert B. Wallis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Wallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Wallis. The network helps show where Robert B. Wallis may publish in the future.

Co-authorship network of co-authors of Robert B. Wallis

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Wallis. A scholar is included among the top collaborators of Robert B. Wallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Wallis. Robert B. Wallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallis, Robert B., et al.. (1997). Reduction of plasma clot stability by a novel factor XIIIa inhibitor from the Giant Amazon Leech, Haementeria ghilianii. Blood Coagulation & Fibrinolysis. 8(5). 291–295. 6 indexed citations
2.
Sawyer, Roy T., et al.. (1997). Tridegin, a Novel Peptidic Inhibitor of Factor XIIIa from the Leech, Haementeria ghilianii, Enhances Fibrinolysis In Vitro. Thrombosis and Haemostasis. 77(5). 959–963. 26 indexed citations
3.
Butler, Kevin, et al.. (1993). Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat. Blood Coagulation & Fibrinolysis. 4(3). 459–464. 25 indexed citations
4.
Wallis, Robert B.. (1993). The Effect of Recombinant Hirudin on Arterial Thrombosis. Advances in experimental medicine and biology. 340. 237–241. 4 indexed citations
5.
Wallis, Robert B.. (1993). Patent Update: Inhibitors of Coagulation Factor Xa: From Macromolecular Beginnings to Small Molecules. 3(8). 1173–1179. 1 indexed citations
6.
Butler, K., et al.. (1992). A non-occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity. Blood Coagulation & Fibrinolysis. 3(2). 155–166. 10 indexed citations
7.
Ambler, John, et al.. (1991). The Effects of Recombinant Desulphatohirudin on Arterial Thrombosis in Rats. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 73–79. 9 indexed citations
8.
Wallis, Robert B.. (1991). Platelets and Atherosclerosis. Blood Coagulation & Fibrinolysis. 2(3). 484–484.
9.
Ambler, John, et al.. (1989). Recombinant Desulphatohirudin (CGP 39393) Anticoagulant and Antithrombotic Properties In Vivo. Thrombosis and Haemostasis. 61(1). 77–80. 45 indexed citations
10.
11.
Ambler, John, et al.. (1985). CGS 12970: a novel, long acting thromboxane synthetase inhibitor. British Journal of Pharmacology. 86(2). 497–504. 17 indexed citations
12.
Ambler, John, et al.. (1983). The platelet inhibitory effect of hydralazine: comparison with hypotensive effects in the rat. Thrombosis Research. 32(2). 239–243. 4 indexed citations
13.
14.
Hallam, Trevor J., et al.. (1982). Desensitisation in Human and Rabbit Blood Platelets. Thrombosis and Haemostasis. 47(3). 278–284. 25 indexed citations
15.
16.
Wallis, Robert B., et al.. (1981). The Effect of Sulphinpyrazone and Its Metabolites on Platelet Function <i>in vitro</i> and <i>ex vivo</i>. Pathophysiology of Haemostasis and Thrombosis. 10(3). 165–175. 19 indexed citations
17.
Turney, John H., et al.. (1981). The Effects of Two Different Dosage Regimens of Sulphinpyrazone on Platelet Function <i>ex vivo</i> and Blood Chemistry in Man. Pathophysiology of Haemostasis and Thrombosis. 10(3). 153–164. 15 indexed citations
18.
19.
Butler, Kym L., et al.. (1979). Biphasic Prolonged Inhibition of Platelet Prostaglandin Biosynthesis Induced by Sulphinpyrazone. Thrombosis and Haemostasis. 2 indexed citations
20.
Wallis, Robert B.. (1978). The Role of Prostaglandins in the ADP-Induced Aggregation of Rabbit Platelets Shown by the Use of 15-Hydroxyprostaglandin Dehydrogenase. Thrombosis and Haemostasis. 39(3). 725–732. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward M. Driscoll Breakdown of academic impact, for papers by Shin-ichiro Ashida Breakdown of academic impact, for papers by Jane May Breakdown of academic impact, for papers by Carol M. Ingerman Breakdown of academic impact, for papers by H Weisenberger Breakdown of academic impact, for papers by Johan Beetens Breakdown of academic impact, for papers by Yoshimi Imura Breakdown of academic impact, for papers by H Hess Breakdown of academic impact, for papers by Martina H. Lundberg Breakdown of academic impact, for papers by Miriam H. Fukami
Rankless by CCL
2026